Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 2.6B | 3.5B | 2.7B | 3.1B |
Cost of revenue | 1.5B | 2.0B | 1.5B | 1.7B |
Gross profit | 1.0B | 1.5B | 1.2B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.1B | 1.1B | 1.0B | 1.0B |
Other operating expenses | 50M | 40M | 50M | 51M |
Operating income | -15M | 383M | 135M | 350M |
Non operating interest income | ||||
Income | 2M | 5M | 4M | 6M |
Expense | 64M | 63M | 64M | 63M |
Other income expense | — | — | — | — |
Pretax income | -77M | 324M | 75M | 293M |
Tax provision | -8M | 67M | 17M | 62M |
Net income | -69M | 257M | 58M | 231M |
Basic EPS | -0.5 | 1.7 | 0.4 | 1.5 |
Diluted EPS | -0.5 | 1.7 | 0.4 | 1.5 |
Basic average shares | 153.0M | 152.0M | 151.5M | 151.5M |
Diluted average shares | 153.0M | 152.0M | 153.2M | 153.3M |
EBITDA | 234M | 628M | 379M | 593M |
Net income from continuing op. | -15M | 383M | 135M | 351M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |